Neurokinin3-R agonism in aged rats has anxiolytic-, antidepressant-, and promnestic-like effects and stimulates ACh release in frontal cortex, amygdala and hippocampus

European Neuropsychopharmacology

Volumn 21, Issue 6, 2011, Pages 484-494

  Schable S ^a   Topic, B ^a   Buddenberg, T ^a   Petri, D ^a   Huston, J P ^a   De Souza Silva, M A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Acetylcholine; Aging; Antidepressant like; Anxiety; Episodic like memory; Forced swimming test; In vivo microdialysis; Neurokinin; NK3 receptor agonist; Open field

Indexed keywords

ACETYLCHOLINE; NEUROKININ 3 RECEPTOR; SENKTIDE;

ACETYLCHOLINE RELEASE; AGONIST; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; EPISODIC MEMORY; FOREBRAIN; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; TRANQUILIZING ACTIVITY;

ACETYLCHOLINE; AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BRAIN; CHOLINERGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FRONTAL LOBE; HIPPOCAMPUS; MALE; MEMORY; MICRODIALYSIS; MOTOR ACTIVITY; NOOTROPIC AGENTS; PEPTIDE FRAGMENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-3; SUBSTANCE P; SWIMMING;

EID: 79955649973     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.11.010     Document Type: Article

References (91)

1. Araujo D.M., Lapchak P.A., Meaney M.J., Collier B., Quirion R. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites. J. Neurosci. 1990, 10:3069-3078.
2. Armstrong D.M., Hersh L.B., Gage F.H. Morphologic alterations of cholinergic processes in the neocortex of aged rats. Neurobiol. Aging 1988, 9:199-205.
3. Arnaiz, E., Almkvist, O., 2003. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurol. Scand. Suppl. 179, 34-41.
4. Belleville S., Sylvain-Roy S., de BC., Menard M.C. Characterizing the memory changes in persons with mild cognitive impairment. Prog. Brain Res. 2008, 169:365-375.
5. Boix F., Pfister M., Huston J.P., Schwarting R.K. Substance P decreases extracellular concentrations of acetylcholine in neostriatum and nucleus accumbens in vivo: possible relevance for the central processing of reward and aversion. Behav. Brain Res. 1994, 63:213-219.
6. Calabrese E.J., Blain R. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol. Appl. Pharmacol. 2005, 202:289-301.
7. Chang Q., Gold P.E. Impaired and spared cholinergic functions in the hippocampus after lesions of the medial septum/vertical limb of the diagonal band with 192 IgG-saporin. Hippocampus 2004, 14:170-179.
8. Chen L.W., Wei L.C., Liu H.L., Ding Y.Q., Zhang H., Rao Z.R., Ju G., Chan Y.S. Cholinergic neurons expressing neuromedin K receptor (NK3) in the basal forebrain of the rat: a double immunofluorescence study. Neuroscience 2001, 103:413-422.
9. Chen L.W., Wei L.C., Liu H.L., Qiu Y., Chan Y.S. Cholinergic neurons expressing substance P receptor (NK(1)) in the basal forebrain of the rat: a double immunocytochemical study. Brain Res. 2001, 904:161-166.
10. Ciccocioppo R., Panocka I., Polidori C., Froldi R., Angeletti S., Massi M. Mechanism of action for reduction of ethanol intake in rats by the tachykinin NK-3 receptor agonist aminosenktide. Pharmacol. Biochem. Behav. 1998, 61:459-464.
11. Cooper J.D., Sofroniew M.V. Increased vulnerability of septal cholinergic neurons to partial loss of target neurons in aged rats. Neuroscience 1996, 75:29-35.
12. Dableh L.J., Yashpal K., Rochford J., Henry J.L. Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat. Eur. J. Pharmacol. 2005, 507:99-105.
13. Dam T.V., Escher E., Quirion R. Visualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktide. Brain Res. 1990, 506:175-179.
14. Damsma G., Vanbueren D.L., Westerink B.H.C., Horn A.S. Determination of acetylcholine and choline in the femtomole range by means of HPLC, a post-column enzyme reactor, and electrochemical detection. Chromatographia 1987, 24:827-831.
15. Davis M. The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 1992, 15:353-375.
16. De Lacalle S., Cooper J.D., Svendsen C.N., Dunnett S.B., Sofroniew M.V. Reduced retrograde labelling with fluorescent tracer accompanies neuronal atrophy of basal forebrain cholinergic neurons in aged rats. Neuroscience 1996, 75:19-27.
17. de Lima M.N., Laranja D.C., Caldana F., Bromberg E., Roesler R., Schroder N. Reversal of age-related deficits in object recognition memory in rats with l-deprenyl. Exp. Gerontol. 2005, 40:506-511.
18. De Souza Silva M.A., Mello E.L., Muller C.P., Jocham G., Maior R.S., Huston J.P., Tomaz C., Barros M. Interaction of the tachykinin NK3 receptor agonist senktide with behavioral effects of cocaine in marmosets (Callithrix penicillata). Peptides 2006, 27:2214-2223.
19. De Souza Silva M.A., Müller C., Huston J.P. Microdialysis in the brain of anesthetized vs. freely moving animals. Handbook of Microdialysis: Methods, Applications and Clinical Aspects 2007, Elsevier Science Publishers, Amsterdam. B.H.C. Westerink, T. Cremers (Eds.).
20. Degroot A., Wolff M.C., Nomikos G.G. Acute exposure to a novel object during consolidation enhances cognition. NeuroReport 2005, 16:63-67.
21. Del Arco A., Mora F. Neurotransmitters and prefrontal cortex-limbic system interactions: implications for plasticity and psychiatric disorders. J. Neural Transm. 2009, 116:941-952.
22. Dere E., Huston J.P., De Souza Silva M.A. The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci. Biobehav. Rev. 2007, 31:673-704.
23. Eichenbaum H., Dudchenko P., Wood E., Shapiro M., Tanila H. The hippocampus, memory, and place cells: is it spatial memory or a memory space?. Neuron 1999, 23:209-226.
24. Eichenbaum H., Fortin N.J., Ergorul C., Wright S.P., Agster K.L. Episodic recollection in animals: "If it walks like a duck and quacks like a duck ". Learn. Motiv. 2005, 36:190-207.
25. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral-data. Behav. Brain Res. 1988, 31:47-59.
26. Fadda F., Cocco S., Stancampiano R. Hippocampal acetylcholine release correlates with spatial learning performance in freely moving rats. NeuroReport 2000, 11:2265-2269.
27. File S.E. NKP608, an NK1 receptor antagonist, has an anxiolytic action in the social interaction test in rats. Psychopharmacol. Berl 2000, 152:105-109.
28. Fischer, W., Gage, F.H., Bjorklund, A., 1989. Degenerative changes in forebrain cholinergic nuclei correlate with cognitive impairments in aged rats. Eur. J. Neurosci. 1, 34-45.
29. Gage F.H., Chen K.S., Buzsaki G., Armstrong D. Experimental approaches to age-related cognitive impairments. Neurobiol. Aging 1988, 9:645-655.
30. Gallagher, M., Pelleymounter, M.A., 1988. Spatial learning deficits in old rats: a model for memory decline in the aged. Neurobiol. Aging 9, 549-556.
31. Gallagher M., Bizon J.L., Hoyt E.C., Helm K.A., Lund P.K. Effects of aging on the hippocampal formation in a naturally occurring animal model of mild cognitive impairment. Exp. Gerontol. 2003, 38:71-77.
32. Griebel G., Perrault G., Soubrie P. Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents. Psychopharmacol. Berl 2001, 158:241-251.
33. Gron G., Kirstein M., Thielscher A., Riepe M.W., Spitzer M. Cholinergic enhancement of episodic memory in healthy young adults. Psychopharmacol. Berl 2005, 182:170-179.
34. Hannesson D.K., Vacca G., Howland J.G., Phillips A.G. Medial prefrontal cortex is involved in spatial temporal order memory but not spatial recognition memory in tests relying on spontaneous exploration in rats. Behav. Brain Res. 2004, 153:273-285.
35. Hellweg, R., Fischer, W., Hock, C., Gage, F.H., Bjorklund, A., Thoenen, H., 1990. Nerve growth factor levels and choline acetyltransferase activity in the brain of aged rats with spatial memory impairments. Brain Res. 537, 123-130.
36. Huston J.P., Hasenohrl R.U. The role of neuropeptides in learning: focus on the neurokinin substance P. Behav. Brain Res. 1995, 66:117-127.
37. Ingram, D.K., Spangler, E.L., Iijima, S., Ikari, H., Kuo, H., Greig, N.H., London, E.D., 1994. Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis. Life Sci. 55, 2037-2049.
38. Jocham G., Lauber A.C., Muller C.P., Huston J.P., De Souza Silva M.A. Neurokinin 3 receptor activation potentiates the psychomotor and nucleus accumbens dopamine response to cocaine, but not its place conditioning effects. Eur. J. Neurosci. 2007, 25:2457-2472.
39. Jung M., Michaud J.C., Steinberg R., Barnouin M.C., Hayar A., Mons G., Souilhac J., Emonds-Alt X., Soubrie P., Le F.G. Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin NK3 receptor stimulation. Neuroscience 1996, 74:403-414.
40. Kalueff A.V. Neurobiology of memory and anxiety: from genes to behavior. Neural Plast. 2007, 78171.
41. Kameyama T., Ukai M., Shinkai N. Ameliorative effects of tachykinins on scopolamine-induced impairment of spontaneous alternation performance in mice. Meth. Find. Exp. Clin. Pharmacol. 1998, 20:555-560.
42. Kart-Teke E., De Souza Silva M.A., Huston J.P., Dere E. Wistar rats show episodic-like memory for unique experiences. Neurobiol. Learn. Mem. 2006, 85:173-182.
43. Kastin A.J., Pan W. Concepts for biologically active peptides. Curr. Pharm. Des. 2010, 16:3390-3400.
44. Kopf S.R., Benton R.S., Kalfin R., Giovannini M.G., Pepeu G. NO synthesis inhibition decreases cortical ACh release and impairs retention of a conditioned response. Brain Res. 2001, 894:141-144.
45. Kramer M.S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J.J., Reines S.A., Liu G., Snavely D., Wyatt-Knowles E., Hale J.J., Mills S.G., MacCoss M., Swain C.J., Harrison T., Hill R.G., Hefti F., Scolnick E.M., Cascieri M.A., Chicchi G.G., Sadowski S., Williams A.R., Hewson L., Smith D., Carlson E.J., Hargreaves R.J., Rupniak N.M. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 1998, 281:1640-1645.
46. Lasarge C.L., Montgomery K.S., Tucker C., Slaton G.S., Griffith W.H., Setlow B., Bizon J.L. Deficits across multiple cognitive domains in a subset of aged Fischer 344 rats. Neurobiol. Aging 2007, 28:928-936.
47. Lehmann O., Jeltsch H., Lehnardt O., Pain L., Lazarus C., Cassel J.C. Combined lesions of cholinergic and serotonergic neurons in the rat brain using 192 IgG-saporin and 5, 7-dihydroxytryptamine: neurochemical and behavioural characterization. Eur. J. Neurosci. 2000, 12:67-79.
48. Levin E.D., Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacol. Berl 1998, 138:217-230.
49. Li J.S., Chao Y.S. Electrolytic lesions of dorsal CA3 impair episodic-like memory in rats. Neurobiol. Learn. Mem. 2008, 89:192-198.
50. Lister J.P., Barnes C.A. Neurobiological changes in the hippocampus during normative aging. Arch. Neurol. 2009, 66:829-833.
51. Liu R., Ding Y., Aghajanian G.K. Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleus. Neuropsychopharmacology 2002, 27:329-340.
52. Mantha A.K., Moorthy K., Cowsik S.M., Baquer N.Z. Membrane associated functions of neurokinin B (NKB) on Abeta (25-35) induced toxicity in aging rat brain synaptosomes. Biogerontology 2006, 7:19-33.
53. Marco N., Thirion A., Mons G., Bougault I., Le Fur G., Soubrie P., Steinberg R. Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig. Neuropeptides 1998, 32:481-488.
54. Martin S.J., Clark R.E. The rodent hippocampus and spatial memory: from synapses to systems. Cell. Mol. Life Sci. 2007, 64:401-431.
55. Martinez-Serrano, A., Fischer, W., Bjorklund, A., 1995. Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. Neuron 15, 473-484.
56. Massi M., Panocka I., de Caro G. The psychopharmacology of tachykinin NK-3 receptors in laboratory animals. Peptides 2000, 21:1597-1609.
57. McGaugh J.L. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu. Rev. Neurosci. 2004, 27:1-28.
58. McGaughy J., Dalley J.W., Morrison C.H., Everitt B.J., Robbins T.W. Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task. J. Neurosci. 2002, 22:1905-1913.
59. Mesulam M.M., Mufson E.J., Wainer B.H., Levey A.I. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 1983, 10:1185-1201.
60. Mumby D.G., Gaskin S., Glenn M.J., Schramek T.E., Lehmann H. Hippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts. Learn. Mem. 2002, 9:49-57.
61. Nordquist R.E., Delenclos M., Ballard T.M., Savignac H., Pauly-Evers M., Ozmen L., Spooren W. Cognitive performance in neurokinin 3 receptor knockout mice. Psychopharmacology 2008, 198:211-220.
62. Panocka I., Massi M., Lapo I., Swiderski T., Kowalczyk M., Sadowski B. Antidepressant-type effect of the NK3 tachykinin receptor agonist aminosenktide in mouse lines differing in endogenous opioid system activity. Peptides 2001, 22:1037-1042.
63. Patel, S., Tariot, P.N., 1991. Pharmacologic models of Alzheimer's disease. Psychiatr. Clin. North Am. 14, 287-308.
64. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, Sydney, 1986. 2nd Ed.
65. Pesold C., Treit D. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 1995, 671:213-221.
66. Potter P.E., Meek J.L., Neff N.H. Acetylcholine and choline in neuronal tissue measured by HPLC with electrochemical detection. J. Neurochem. 1983, 41:188-194.
67. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 2003, 463:3-33.
68. Ribeiro S.J., Teixeira R.M., Calixto J.B., De Lima T.C. Tachykinin NK(3)receptor involvement in anxiety. Neuropeptides 1999, 33:181-188.
69. Rigby M., O'Donnell R., Rupniak N.M. Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain. J. Comp. Neurol. 2005, 490:335-353.
70. Robitsek R.J., Fortin N.J., Koh M.T., Gallagher M., Eichenbaum H. Cognitive aging: a common decline of episodic recollection and spatial memory in rats. J. Neurosci. 2008, 28:8945-8954.
71. Rowe W.B., Spreekmeester E., Meaney M.J., Quirion R., Rochford J. Reactivity to novelty in cognitively-impaired and cognitively-unimpaired aged rats and young rats. Neuroscience 1998, 83:669-680.
72. Saffroy M., Torrens Y., Glowinski J., Beaujouan J.C. Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites. Neuroscience 2003, 116:761-773.
73. Salome N., Stemmelin J., Cohen C., Griebel G. Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils. Pharmacol. Biochem. Behav. 2006, 83:533-539.
74. Schäble, S., Huston, J.P., De Souza Silva, M.A., 2010. Neurokinin(2)-R in medial septum regulate hippocampal and amygdalar ACh release induced by intraseptal application of neurokinins A and B. Hippocampus. doi:10.1002/hipo.20847.
75. Schulz D., Huston J.P., Buddenberg T., Topic B. "Despair" induced by extinction trials in the water maze: relationship with measures of anxiety in aged and adult rats. Neurobiol. Learn. Mem. 2007, 87:309-323.
76. Siuciak J.A., McCarthy S.A., Martin A.N., Chapin D.S., Stock J., Nadeau D.M., Kantesaria S., Bryce-Pritt D., McLean S. Disruption of the neurokinin-3 receptor (NK3) in mice leads to cognitive deficits. Psychopharmacol. Berl 2007, 194:185-195.
77. Sperling R.A., Dickerson B.C., Pihlajamaki M., Vannini P., LaViolette P.S., Vitolo O.V., Hedden T., Becker J.A., Rentz D.M., Selkoe D.J., Johnson K.A. Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med. 2010, 12:27-43.
78. Steinberg R., Rodier D., Souiclhac J., Bougault I., Emonds-Alt X., Soubrie P., Le Fur G. Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: an in vivo microdialysis study. J. Neurochem. 1995, 65:2543-2548.
79. Steinberg R., Alonso R., Rouquier L., Desvignes C., Michaud J.C., Cudennec A., Jung M., Simiand J., Griebel G., Emonds-Alt X., Le Fur G., Soubrie P. SSR240600 [(R)-2-(1-[2-[4-[2-[3, 5-bis(trifluoromethyl)phenyl]acetyl]-2-(3, 4-dichloro phenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin 1 receptor: II. neurochemical and behavioral characterization. J. Pharmacol. Exp. Ther. 2002, 303:1180-1188.
80. Stoessl A.J., Hill D.R. Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktide. Brain Res. 1990, 534:1-7.
81. Stoessl A.J., Dourish C.T., Young S.C., Williams B.J., Iversen S.D., Iversen L.L. Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse. Neurosci. Lett. 1987, 80:321-326.
82. Stoessl A.J., Dourish C.T., Iversen S.D. Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT. Brain Res. 1990, 517:111-116.
83. Takei N., Nihonmatsu I., Kawamura H. Age-related decline of acetylcholine release evoked by depolarizing stimulation. Neurosci. Lett. 1989, 101:182-186.
84. Teri L., Ferretti L.E., Gibbons L.E., Logsdon R.G., McCurry S.M., Kukull W.A., McCormick W.C., Bowen J.D., Larson E.B. Anxiety of Alzheimer's disease: prevalence, and comorbidity. J. Gerontol. A Biol. Sci. Med. Sci. 1999, 54:M348-M352.
85. Tulving E. Episodic memory: from mind to brain. Annu. Rev. Psychol. 2002, 53:1-25.
86. Ukai M., Shinkai N., Kameyama T. Involvement of dopamine receptors in beneficial effects of tachykinins on scopolamine-induced impairment of alternation performance in mice. Eur. J. Pharmacol. 1998, 350:39-45.
87. Van den Berg, C.M., Kazmi, Y., Jann, M.W., 2000. Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly. Drugs Aging 16, 123-138.
88. Vloeberghs E., Van Dam D., Franck F., Staufenbiel M., De Deyn P.P. Mood and male sexual behaviour in the APP23 model of Alzheimer's disease. Behav. Brain Res. 2007, 180:146-151.
89. Wenk G.L., Zajaczkowski W., Danysz W. Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B. Behav. Brain Res. 1997, 83:129-133.
90. Winters B.D., Bussey T.J. Transient inactivation of perirhinal cortex disrupts encoding, retrieval, and consolidation of object recognition memory. J. Neurosci. 2005, 25:52-61.
91. Zlomuzica A., Dere E., Huston J.P., De Souza Silva M.A. NK(3) receptor agonism promotes episodic-like memory in mice. Neurobiol. Learn. Mem. 2008, 90:420-425.